Colon Cancer Clinical Trial
— SILSOfficial title:
Single Incision Laparoscopic Right Hemi-colectomy Pilot Study
Verified date | March 2014 |
Source | University of British Columbia |
Contact | n/a |
Is FDA regulated | No |
Health authority | Canada: Health Canada |
Study type | Interventional |
The investigators will document the success for completing laparoscopic resection of cancer
in the right colon using a new single port access technique. The current procedure requires
4 incisions for 4 separate ports. With technological advancement of newly designed
instruments it is now possible to do the same laparoscopic procedure through a single port.
The investigators want to demonstrate here in British Columbia that it is a safe procedure
with similar success and outcomes compared to the standard 4-port laparoscopic operation.
The investigators propose that this procedure may provide early discharge due to less pain
and also be associated with less wound infection and hernia complications. The single
incision will have improved cosmesis compared to the standard 4-port standard laparoscopic
procedure.
Status | Withdrawn |
Enrollment | 0 |
Est. completion date | May 2012 |
Est. primary completion date | May 2012 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Adult patients age 19 years or older diagnosed with resectable right colon cancer Exclusion Criteria: - Advanced cancer on routine preoperative CT (local invasion, distant metastases) - maximum diameter of cancer > 5cm - previous abdominal surgery - emergency surgery - pregnancy - ages < 18 years old - ASA (American Society of Anesthesiologists) Class III or above - Any other contraindications to laparoscopic surgery - Non-English speaking/reading or unable to give consent |
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University of British Columbia | Tyco Healthcare Group |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Successful completion of the right hemicolectomy | The first and main outcome is to assess if right hemicolectomy can be safely performed using the Single Port. | 1 day | Yes |
Secondary | Use of additional ports and reason | This is to see that even using roticulating laparoscopic instruments, how often and how many additional ports were placed. | 1 day | No |
Secondary | Conversion to an open procedure and reason | 1 day | Yes | |
Secondary | Duration of surgery | 1 Day | No | |
Secondary | Operative complications | this includes, bleeding complications and inadvertant bowel or other abdominal visceral injury. | 1 Day | Yes |
Secondary | Total Length of surgical incision (cm) | 30 days | No | |
Secondary | Postoperative analgesia requirements (total opioid used) | total mg of Morphine used. If morphine is not used and alternative opioid used, this will be coverted standard conversion to equivalent dose of Morphine. | 30 days | No |
Secondary | 30 Day Mortality | 30 Days | Yes | |
Secondary | Length of postoperative hospital stay | 30days | No | |
Secondary | Pathological Cancer stage (TNM) | 15 Days | No | |
Secondary | Pathology: Resection margin clearance | 15 Days | No | |
Secondary | Number of lymph nodes assessed | 15 Days | Yes | |
Secondary | Total Number of Surgical Incisions | 1 Day | No | |
Secondary | Wound Infection | yes/no, Deep Surgical site infection vs Superficial Surgical site infection. | 30 Days | Yes |
Secondary | Postoperative complications: Requirement of Re-operation | Yes/NO | 30 Days | Yes |
Secondary | Postoperative complications: Reason for reoperation | (if needed re-operation) | 30 Days | Yes |
Secondary | Postop Complications: Wound Dehiscence | 30 Day | Yes | |
Secondary | Postoperative Complications: Others | including deep vein thrombosis/pulmonary embolism (DVT/PE), myocardial infarction, stroke and pneumonia | 30 Day | Yes |
Secondary | 30 Day Re-admission | 30 Days | Yes | |
Secondary | Postoperative Measure of Pain | Visual Analogue Scale to quantify pain on POD#1, #2 AND #3 | 3 DAYS | Yes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05551052 -
CRC Detection Reliable Assessment With Blood
|
||
Completed |
NCT03457454 -
Reducing Rural Colon Cancer Disparities
|
||
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT04088955 -
A Digimed Oncology PharmacoTherapy Registry
|
||
Recruiting |
NCT06010862 -
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
|
Phase 1 | |
Terminated |
NCT01347645 -
Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer
|
Phase 1/Phase 2 | |
Completed |
NCT03390907 -
Hybrid APC Assisted EMR for Large Colon Polyps
|
N/A | |
Recruiting |
NCT03175224 -
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
|
Phase 2 | |
Completed |
NCT04079478 -
The AID Study: Artificial Intelligence for Colorectal Adenoma Detection
|
||
Active, not recruiting |
NCT04057274 -
Acute Effect of modeRate-intensity aerOBIc Exercise on Colon Cancer Cell Growth
|
N/A | |
Recruiting |
NCT03190941 -
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05147545 -
Impact of Exercise and Hyperlipidic Meal on Free Circulating DNA in Patients With Metastatic Colonic Cancer and Healthy Subjects
|
N/A | |
Recruiting |
NCT05026268 -
The Laparoscopic Right Colectomy With Intracoroporeal Anastomosis
|
N/A | |
Not yet recruiting |
NCT03277235 -
Effect of a Resilience Model-Based Care Plan in Newly Diagnosed Colorectal Cancer Patients
|
N/A | |
Active, not recruiting |
NCT02959541 -
PK/PD Investigation of Calciumfolinat in Blood, Tumor and Adjacent Mucosa in Patient With Colon Cancer
|
N/A | |
Active, not recruiting |
NCT02730702 -
Colon Cancer Risk-stratification Via Optical Analysis of Rectal Ultrastructure
|
||
Completed |
NCT02810652 -
Perioperative Geriatrics Intervention for Older Cancer Patients Undergoing Surgical Resection
|
N/A | |
Recruiting |
NCT02577627 -
Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC
|
N/A | |
Terminated |
NCT02628535 -
Safety Study of MGD009 in B7-H3-expressing Tumors
|
Phase 1 | |
Recruiting |
NCT02526836 -
Complete Mesocolic Excision With Central Vessel Ligation Compared With Conventional Surgery for Colon Cancer
|
Phase 2/Phase 3 |